MATRIXLABS

Matrix Laboratories Limited has informed the Exchange that the Company has received disclosures under regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 from Employees of the Company. In this connection, the company has submitted to the Exchange the disclosure under regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_reg_17082009

Matrix Laboratories Limited has informed the Exchange that the Board of Directors of the Company vide their Resolutions passed through circulation on May 03, 2009 approved the following proposals: (1) Amendments to the ESOP 2004 Plan, ESOP 2006-1 Plan and ESOP 2006-2 Plan (collectively 'Esop Plans') subject to the approval of the Shareholders. (2) Issue and allotment of upto 1,839,345 equity shares of the Company to a trust to be formed and settled by the Company with the object, inter alia, of the benefit of the present, former and future employees and directors of the Company and of subsidia

Matrix Laboratories Limited has informed the Exchange that Mr. K. Jagan Mohan Rao has sold 1875 shares of the total share capital of Matrix Laboratories Limited on April 25, 2006. The mode of sale is through Stock Exchange and the shareholding of Mr. K. Jagan Mohan Rao after the said sale is nil shares of the total share capital of Matrix Laboratories Limited.

Matrix Laboratories Limited has informed the Exchange that Merrill Lynch Capital Markets Espana S.A.SV has acquired 8,80,000 shares aggregating to 0.58% of the total paid up capital of Matrix Laboratories Ltd on April 13, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Merrill Lynch Capital Markets Espana S.A.SV after the said acquisition is 82,64,869 shares aggregating to 5.38% of the total paid up capital of Matrix Laboratories Ltd.

Citibank, N.A. has informed the Exchange that Merrill Lynch Capital Markets Espana S.A.SV alongwith PAC: Merrill Lynch International has acquired 8,80,000 shares aggregating to 0.58% of the total paid up capital of Matrix Laboratories Ltd on April 13, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Merrill Lynch Capital Markets Espana S.A.SV alongwith PAC: Merrill Lynch International after the said acquisition is 8,264,869 shares aggregating to 5.38% of the total paid up capital of Matrix Laboratories Ltd.

Matrix Laboratories Limited has submitted to the Exchange the Annual Disclosure of the shareholdings of Directors / Employees of the Company in Matrix Laboratories Limited as on March 31, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that All times Project Ltd has sold 7000000 shares aggregating to 4.56% of the total paid up capital of Matrix Laboratories Limited on March 31, 2006. The mode of sale is through Open Market and the shareholding of All times Project Ltd after the said sale is 41,900 shares aggregating to 0.02% of the total paid up capital of Matrix Laboratories Limited. The company has further informed the Exchange that subsequent to sale of substantial holding by All time projects Ltd and also in line with their request, the Company is removing All Time Pr

Matrix Laboratories Limited has informed the Exchange that the company has received disclosure from Employees/Director regarding their shareholding in the company. The date of acquisition is March 21,2006 and the mode of acquisition is Allotment under ESOP 2004. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Matrix Laboratories Limited has informed the Exchange that Mr. S. Srinivasan, Sr.Vice President of the Company has sold 2,500 shares of Matrix Laboratories Limited on March 08, 2006. The mode of sale is through Stock Exchange and the shareholding of Mr. S. Srinivasan after the said sale is 38,060 shares of Matrix Laboratories Limited.

Matrix Laboratories Limited has informed the Exchange that Mr. S. Srinivasan, Sr.Vice President of the Company has sold 2000 shares of Matrix Laboratories Limited on February 14, 2006. The mode of sale is through Stock Exchange and the shareholding of Mr. S. Srinivasan after the said sale is 40560 shares of Matrix Laboratories Limited.

Matrix Laboratories Limited has informed the Exchange that Mr. N. Prasad, Executive Chairman of the Company has sold 20,00,000 shares of Matrix Laboratories Limited on February 17, 2006. The mode of sale is through Stock Exchange and the shareholding of Mr. N. Prasad after the said sale is 1,56,70,010 shares aggregating to 10.23% of the total share capital of Matrix Laboratories Limited.

Matrix Laboratories Limited has informed the Exchange that Mr. S. Srinivasan, Sr.Vice President of the Company has sold 1000 shares of Matrix Laboratories Limited on January 09, 2006. The mode of sale is through Stock Exchange and the shareholding of Mr. S. Srinivasan after the said sale is 42560 shares aggregating to 0.03% of the share capital of Matrix Laboratories Limited.

Matrix Laboratories Limited has informed the Exchange that the Company has received disclosures from Mr. N. Prasad, Chairman & Chief Executive Officer regarding the sale of shares of the Company. The details of the same are as follows: 1) Mr. N. Prasad has sold 4,00,000 shares and his shareholding after the said sale is 1,76,70,010 shares aggregating to 11.80% of the share capital of Matrix Laboratories Limited; 2) Mr. N. Prasad HUF has sold 6,00,000 shares and his shareholding after the said sale is 6,00,000 shares aggregating to 0.40% of the share capital of Matrix Laboratories Limited. The

Matrix Laboratories Limited has submitted to the Exchange the Annual Disclosure of the shareholdings of Directors / Employees of the Company in Matrix Laboratories Limited as on March 31, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding disclosures received from the employees of the Company for sale of shares held by them. The details are as follows: 1) Mr. V.V.Ravi Kumar has sold 1000 shares of Matrix Laboratories Limited on December 08, 2004. The mode of sale is through the open market and his shareholding after the said sale is 1276 shares representing 0.01% of the total share capital of the company.2) Mr. M.Bhaskaraiah has sold 500 shares of Matrix Laboratories Limited on December 08, 2004. The mode of sale is through the open market and his shareholding afte

Matrix Laboratories Limited has informed the Exchange regarding disclosures received from Dr. Mohan, employee of the Company. The details are as follows: 1) Dr. B Mohan has sold 500 shares on November 23, 2004. The mode of sale is through the open market and his shareholding after the said sale is 500 shares.

Matrix Laboratories Limited has informed the Exchange regarding disclosures received from Director and Officers of the company for sale of equity shares. The details are as follows: 1) Dr. Dr. C Satyanarayana, Director has transferred 49000 equity shares of the company to his wife Mrs. C Naga Rani. The shareholding after the transfer is 29900 shares amounting to 0.21% of the paid up capital of the company. 2) Mr. P Rajani has sold 400 shares on October 05, 2004 through off market. The shareholding after the sale is 305 shares. 3) Mr. N Prakash has sold 2000 shares through open market on Sept

Matrix Laboratories Limited has informed the Exchange the following: 1) India Newbridge Investments Ltd has purchased 841455 shares amounting to 5.78% of the total paid up capital of Matrix Laboratories Ltd. The shareholding of India Newbridge Investments Ltd after the acquisition is 2666455 shares amounting to 18.33% of the paid up capital of Matrix Laboratories Ltd. The mode of acquisition is through open offer and the date of acquisition is September 20, 2004. 2) Maxwell (Mauritius) Pte Ltd has purchased 8,41,456 shares amounting to 5.78% of the paid up capital of Matrix Laboratories Ltd. T

Matrix Laboratories Limited has informed the Exchange that India Newbridge Coinvestment Ltd has purchased 766667 shares amounting to 5.27% of the paid up capital of Matrix Laboratories Ltd. The shareholding of India Newbridge Coinvestment Ltd after the acquisition is 766667 shares amounting to 5.27% of the paid up capital of Matrix Laboratories Ltd. The mode of acquisition is through open offer and the date of acquisition is September 20, 2004.

Citibank NA has informed the Exchange regarding a 2% increase in the holdings of their client Maxwell (Mauritius) PTE Ltd. in the scrip Matrix Laboratories Ltd. The details of the transactions are as follows: - [1] Maxwell (Mauritius) PTE Ltd. has on May 25, 2004 acquired 11,25,000 shares amounting to 7.73% of the voting rights of Matrix Laboratories Limited. The mode of acquisition is through Preferential Allotment.(2) Maxwell (Mauritius) PTE Ltd has on September 13, 2004 acquired 8,41,456 shares amounting to 5.78% of the voting rights of Matrix Laboratories Limited. The mode of acquisition i